Remove Angina Remove Chest Pain Remove Coronary Artery Disease
article thumbnail

GE HealthCare and Medis Medical Imaging Announce Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease

DAIC

Together, the two companies will work to further the development and commercialization of Medis Quantitative Flow Ratio (Medis QFR), a non-invasive approach to the assessment of coronary physiology, as part of GE HealthCare’s interventional cardiology portfolio built around the Allia Platform. Use Heart to Act on Angina.

article thumbnail

Case Report: Vasospastic angina presenting as phantom odor perception

Frontiers in Cardiovascular Medicine

BackgroundVasospastic angina usually presents with intermittent episodes of chest pain. It can rarely be associated with the perception of phantom odors.Case summaryA 69-year-old woman presented for evaluation of intermittent shortness of breath and chest pain.

Angina 52
article thumbnail

Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2

Open Heart

Aims Guidelines for suspected cardiac chest pain have used historical risk stratification tools, advocating invasive coronary angiography (ICA) first-line in those at highest risk. 12) Questionnaire and EuroQol-5 Dimension Questionnaire were recorded.

article thumbnail

How High Blood Pressure Affects Your Heart and What You Can Do About It

MIBHS

Coronary Artery Disease (CAD) : High blood pressure accelerates the development of CAD by promoting the buildup of plaques in the coronary arteries. This condition reduces blood flow to the heart, increasing the risk of angina (chest pain) and heart attacks.

article thumbnail

BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes

DAIC

Results from the open label roll-in cohort of patients having chronic myocardial ischemia with refractory angina showed an average increase in exercise tolerance of 107 seconds and an average of 82% reduction in angina episodes at the primary six-month follow-up endpoint compared to before receiving the study treatment.

article thumbnail

Non-ischemic phenotypes of low-risk chest pain patients based on exercise stress echocardiography: a pilot study

Frontiers in Cardiovascular Medicine

Abnormal stress biomarkers [regional wall motion abnormalities (RWMAs), ST-segment depression, induced angina, peak systolic blood pressure, force-based contractile reserve (CR), heart rate reserve (HRR), and low exercise capacity] were used for phenotyping.

article thumbnail

Importance of provoked spasms at the sites of nonobstructive stenosis as well as at the sites of obstructive stenosis in patients with obstructive coronary arteries and coronary spasm

Coronary Artery Disease Journal

Objectives There are few reports regarding the prognosis in patients with obstructive coronary artery disease (OCAD) and vasospastic angina (VSA). An obstructed coronary artery was defined as ≥50% luminal narrowing.